Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study - PubMed (original) (raw)
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study
A Gastaldelli et al. Diabetes. 2000 Aug.
Abstract
The contribution of gluconeogenesis (GNG) to endogenous glucose output (EGO) in type 2 diabetes is controversial. Little information is available on the separate influence of obesity on GNG. We measured percent GNG (by the 2H2O technique) and EGO (by 6,6-[2H]glucose) in 37 type 2 diabetic subjects (9 lean and 28 obese, mean fasting plasma glucose [FPG] 8.3 +/- 0.3 mmol/l) and 18 control subjects (6 lean and 12 obese) after a 15-h fast. Percent GNG averaged 47 +/- 5% in lean control subjects and was significantly increased in association with both obesity (P < 0.01) and diabetes (P = 0.004). By multivariate analysis, percent GNG was independently associated with BMI (partial r = 0.27, P < 0.05, with a predicted increase of 0.9% per BMI unit) and FPG (partial r = 0.44, P = 0.0009, with a predicted increase of 2.7% per mmol/l of FPG). In contrast, EGO was increased in both lean and obese diabetic subjects (15.6 +/- 0.5 micromol x min(-1) x kg(-1) of fat-free mass, n = 37, P = 0.002) but not in obese nondiabetic control subjects (13.1 0.7, NS) as compared with lean control subjects (12.4 +/- 1.4). Consequently, gluconeogenic flux (percent GNG x EGO) was increased in obesity (P = 0.01) and markedly elevated in diabetic subjects (P = 0.0004), whereas glycogenolytic flux was reduced only in association with obesity (P = 0.05). Fasting plasma glucagon levels were significantly increased in diabetic subjects (P < 0.05) and positively related to EGO, whereas plasma insulin was higher in obese control subjects than lean control subjects (P = 0.05) and unrelated to measured glucose fluxes. We conclude that the percent contribution of GNG to glucose release after a 15-h fast is independently and quantitatively related to the degree of overweight and the severity of fasting hyperglycemia. In obese individuals, reduced glycogenolysis ensures a normal rate of glucose output. In diabetic individuals, hyperglucagonemia contributes to inappropriately elevated rates of glucose output from both GNG and glycogenolysis.
Similar articles
- Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients.
Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E. Gastaldelli A, et al. Diabetes. 2001 Aug;50(8):1807-12. doi: 10.2337/diabetes.50.8.1807. Diabetes. 2001. PMID: 11473042 - Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis.
Gastaldelli A, Miyazaki Y, Pettiti M, Buzzigoli E, Mahankali S, Ferrannini E, DeFronzo RA. Gastaldelli A, et al. J Clin Endocrinol Metab. 2004 Aug;89(8):3914-21. doi: 10.1210/jc.2003-031941. J Clin Endocrinol Metab. 2004. PMID: 15292327 - Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, Buzzigoli E, Sironi AM, Cersosimo E, Ferrannini E, Defronzo RA. Gastaldelli A, et al. Gastroenterology. 2007 Aug;133(2):496-506. doi: 10.1053/j.gastro.2007.04.068. Epub 2007 May 1. Gastroenterology. 2007. PMID: 17681171 - Gluconeogenesis in the fetus and neonate.
Kalhan S, Parimi P. Kalhan S, et al. Semin Perinatol. 2000 Apr;24(2):94-106. doi: 10.1053/sp.2000.6360. Semin Perinatol. 2000. PMID: 10805165 Review. - Indirect calorimetry.
Jéquier E, Felber JP. Jéquier E, et al. Baillieres Clin Endocrinol Metab. 1987 Nov;1(4):911-35. doi: 10.1016/s0950-351x(87)80011-3. Baillieres Clin Endocrinol Metab. 1987. PMID: 3330435 Review.
Cited by
- Consumption of interesterified palm oil leads inflammation of white adipose tissue and triggers metabolic disturbances in mice on a high-fat diet.
Martins BC, da Silva Ribeiro M, Teixeira AVS, Peixoto TC, Lisboa PC, Martins FF, Souza-Mello V, Daleprane JB. Martins BC, et al. Sci Rep. 2024 May 31;14(1):12530. doi: 10.1038/s41598-024-63488-9. Sci Rep. 2024. PMID: 38822155 Free PMC article. - A new framework for exploratory network mediator analysis in omics data.
Cai Q, Fu Y, Lyu C, Wang Z, Rao S, Alvarez JA, Bai Y, Kang J, Yu T. Cai Q, et al. Genome Res. 2024 May 15;34(4):642-654. doi: 10.1101/gr.278684.123. Genome Res. 2024. PMID: 38719472 Free PMC article. - The Role of Obesity in Type 2 Diabetes Mellitus-An Overview.
Chandrasekaran P, Weiskirchen R. Chandrasekaran P, et al. Int J Mol Sci. 2024 Feb 4;25(3):1882. doi: 10.3390/ijms25031882. Int J Mol Sci. 2024. PMID: 38339160 Free PMC article. Review. - Hepatic glucose metabolism in the steatotic liver.
Scoditti E, Sabatini S, Carli F, Gastaldelli A. Scoditti E, et al. Nat Rev Gastroenterol Hepatol. 2024 May;21(5):319-334. doi: 10.1038/s41575-023-00888-8. Epub 2024 Feb 2. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38308003 Review. - Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice.
Esser N, Mongovin SM, Mundinger TO, Barrow BM, Zraika S. Esser N, et al. Peptides. 2023 Oct;168:171076. doi: 10.1016/j.peptides.2023.171076. Epub 2023 Aug 10. Peptides. 2023. PMID: 37572792
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous